Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert
Zero fees, no slippage
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
Novo Nordisk (NVO.US) Wegovy clinical data outperforms Eli Lilly (LLY.US), leading gains in European healthcare stocks

Novo Nordisk (NVO.US) Wegovy clinical data outperforms Eli Lilly (LLY.US), leading gains in European healthcare stocks

智通财经智通财经2025/09/01 11:17
Show original
By:智通财经

According to Jinse Finance APP, on Monday, European stock markets edged higher, with the healthcare sector serving as the main support. Earlier data showed that Danish pharmaceutical giant Novo Nordisk's (NVO.US) weight-loss drug Wegovy offers better heart protection than the competing product from Eli Lilly (LLY.US), sending Novo Nordisk shares higher.

As of press time, the pan-European Stoxx 600 index was up 0.29% at 551.72 points. Last Friday, the index had just experienced its first weekly decline in four weeks.

Among them, the healthcare sector was one of the best-performing industry sectors of the day. As the fourth-largest healthcare company in the Stoxx index, Novo Nordisk's share price climbed nearly 3%. Previously released real-world comparative data from the company showed that, compared to Eli Lilly's competing drugs Mounjaro (tirzepatide) and Zepbound (tirzepatide injection), Wegovy (semaglutide) can reduce the risk of heart attack, stroke, or death in patients by 57%.

The European market's defense sector also performed strongly, rising by 1.2%. Among them, shares of UK aerospace systems company BAE Systems rose 2%, after Norway announced it had chosen the UK as its strategic partner for the procurement of new frigates, a deal valued at around 10 billion pounds (approximately $13.51 billion).

Last Friday, a US federal appeals court ruled that most of the tariffs imposed by US President Donald Trump were illegal, but allowed these tariffs to remain in effect until mid-October to allow time for further appeals. It is worth noting that, as it was a US holiday on that day, overall market trading volume is expected to remain at a low level throughout the day.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!